(RA) pathogenesis by augmenting autoimmunity, sustaining long term inflammation in the
synovium, and promoting joint damage. Anti-TNF therapy is one of the most efficient and
widely used therapies for RA, although its mechanism is not clarified yet. Earlier we
demonstrated that RA patients have a reduced number of IL-10 producing regulatory B cells
(B10 cells) as compared to healthy individuals and they are functionally impaired. Our aim …